Publications by authors named "Richard Press"

Claim this Profile
I
Impact of germline CHEK2 pathogenic variants on the risk of Acute Myeloid Leukemia and Myelodysplastic syndrome.
Fei Yang, Nicola Long, Jonathan C Savage, Jose Solis-Ruiz, Yu Li, Richard D Press

Cancer Epidemiol Biomarkers Prev· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncogenic mutations exhibit differential sensitivity to tropomyosin receptor kinase inhibitors in patients with acute myeloid leukemia.
Sunil K Joshi, Ariane Huang, Janét Pittsenbarger, Ujwal Shinde, Camilo Posso, Richard D Press

Haematologica· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Landscape of somatic mutations and clonal evolution in NUP98-rearranged adult acute myeloid leukaemia.
Candace Frerich, Peng Li, Philipp W Raess, Jennifer Dunlap, Curtis Lachowiez, Richard Press

Br J Haematol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clonally related benign cephalic histiocytosis, histiocytic sarcoma, and T-cell acute lymphoblastic leukemia: Expanding the spectrum of histiocytic transdifferentiation.
J Connor Thellman, Milie M Fang, Tanaya Neff, George Thomas, Candace Frerich, Richard Press

Pediatr Blood Cancer· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overcoming clinical BCR-ABL1 compound mutant resistance with combined ponatinib and asciminib therapy.
Christopher A Eide, Diana Brewer, Tao Xie, Anna Reister Schultz, Samantha L Savage, Richard D Press

Cancer Cell· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The genomic basis of childhood T-lineage acute lymphoblastic leukaemia.
Petri Pölönen, Danika Di Giacomo, Anna Eames Seffernick, Abdelrahman Elsayed, Shunsuke Kimura, Richard D Press

Nature· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of a New Closed-System Automated RT-qPCR Assay for the Rapid Detection and Monitoring of Common Nucleophosmin Mutations in Patients with Acute Myeloid Leukemia.
Richard D Press, Dana Dressel, Michelle McBean, Ing S Tiong, Matthew W Anderson

Int J Mol Sci· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Samples from patients with AML show high concordance in detection of mutations by NGS at local institutions vs central laboratories.
Uma Borate, Fei Yang, Richard Press, Amy S Ruppert, Dan Jones

Blood Adv· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytogenetically Cryptic Acute Promyelocytic Leukemia: A Diagnostic Challenge.
Maedeh Mohebnasab, Peng Li, Bo Hong, Jennifer Dunlap, Elie Traer, Richard D Press

Int J Mol Sci· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison and validation of the 2022 European LeukemiaNet guidelines in acute myeloid leukemia.
Curtis A Lachowiez, Nicola Long, Jennifer Saultz, Arpita Gandhi, Laura F Newell, Richard Press

Blood Adv· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NGS-defined measurable residual disease (MRD) after initial chemotherapy as a prognostic biomarker for acute myeloid leukemia.
Yonghong Li, Jose Solis-Ruiz, Fei Yang, Nicola Long, Carmen H Tong, Richard D Press

Blood Cancer J· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinguishing STAT3/STAT5B-mutated large granular lymphocyte leukemia from myeloid neoplasms by genetic profiling.
Mark Kavesh, Maedeh Mohebnasab, Marcela Riveros Angel, Wei Xie, Philipp W Raess, Richard D Press

Blood Adv· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive molecular characterization of a rare case of Philadelphia chromosome-positive acute myeloid leukemia.
Mara W Rosenberg, Samantha L Savage, Christopher A Eide, Anna Reister Schultz, Rachel J Cook, Richard D Press

Cold Spring Harb Mol Case Stud· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adult acute myeloid leukemia patients with rearrangement have frequent cryptic translocations and unfavorable outcome.
Wei Xie, Philipp W Raess, Jennifer Dunlap, Cristina Magallanes Hoyos, Hongmei Li, Richard D Press

Leuk Lymphoma· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BCR-ABL+ Chronic Myeloid Leukemia Arising in a Family With Inherited ANKRD26-Related Thrombocytopenia.
Aaron M Tsumura, Brian J Druker, Diana Brewer, Richard Press, Theodore P Braun

JCO Precis Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and prioritization of myeloid malignancy germline variants in a large cohort of adult patients with AML.
Fei Yang, Nicola Long, Tauangtham Anekpuritanang, Daniel Bottomly, Jonathan C Savage, Richard D Press

Blood· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Graft-versus-host disease after liver transplantation is associated with bone marrow failure, hemophagocytosis, and DNMT3A mutations.
Laura F Newell, Jennifer Dunlap, Ken Gatter, Grover C Bagby, Richard D Press

Am J Transplant· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In a multi-institutional cohort of myeloid sarcomas, NFE2 mutation prevalence is lower than previously reported.
Tauangtham Anekpuritanang, Matthew M Klairmont, Joel Gradowski, Kohei Hagiwara, Nathanael G Bailey, Richard D Press

Blood Adv· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel activating JAK1 mutation in chronic eosinophilic leukemia.
William Shomali, Alisa Damnernsawad, Talent Theparee, David Sampson, Quinlan Morrow, Richard Press

Blood Adv· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engrafted Donor-Derived Clonal Hematopoiesis after Allogenic Hematopoietic Cell Transplantation is Associated with Chronic Graft-versus-Host Disease Requiring Immunosuppressive Therapy, but no Adverse Impact on Overall Survival or Relapse.
Laura F Newell, Todd Williams, James Liu, Yun Yu, Yiyi Chen, Richard D Press

Transplant Cell Ther· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insights on mechanisms of clonal evolution in chronic neutrophilic leukemia on ruxolitinib therapy.
Ryan C Stoner, Richard D Press, Julia E Maxson, Jeffrey W Tyner, Kim-Hien T Dao

Leukemia· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Ruxolitinib in Patients With Chronic Neutrophilic Leukemia and Atypical Chronic Myeloid Leukemia.
Kim-Hien T Dao, Jason Gotlib, Michael M N Deininger, Stephen T Oh, Jorge E Cortes, Richard D Press

J Clin Oncol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Discordance between Myeloid Sarcomas and Concurrent Bone Marrows Occurs in Actionable Genes and Is Associated with Worse Overall Survival.
Brian Werstein, Jennifer Dunlap, Michael J Cascio, Robert S Ohgami, Guang Fan, Richard Press

J Mol Diagn· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Utility of Next-Generation Sequencing in Acute Myeloid Leukemia.
Fei Yang, Tauangtham Anekpuritanang, Richard D Press

Mol Diagn Ther· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The combination of NPM1, DNMT3A, and IDH1/2 mutations leads to inferior overall survival in AML.
Jennifer B Dunlap, Jessica Leonard, Mara Rosenberg, Rachel Cook, Richard Press

Am J Hematol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis